Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Gilead Sciences (GILD) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareGILD

Closing price · Nov 19, 2026 $167.13 -1.1% on the day · +33.7% over 12 months 52-week range $116.21 – $174.48
Get GILD alerts
Open-market purchases0 insidersno buys · last 12 months
Insiders selling7last 12 months
Reported sales$109M97 of 98 recent sales pre-planned (10b5-1)
In 15 seconds

No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification, pre-planned 10b5-1 sales) and isn't treated as a signal here.

Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • Next earnings expected around Jan 26, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Sale Johanna Mercier, Chief Comm & Corp Aff Officer sold 13,922 shares at $169.97 ($2.4M).

Trade date
Nov 16, 2026
Disclosed to the SEC
Nov 17, 2026
Type
Pre-planned sale, 10b5-1 (code S)

Read the original SEC filing ↗All GILD insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

GILD insider transactions (Form 4)

Open-market purchases and sales. 89 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Nov 17SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 13,922124,762 held (−10%) $169.97 $2.4M -1.7% —
Nov 17SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 13,178111,584 held (−11%) $171.09 $2.3M -2.3% —
Nov 17SEC Andrew D. DickinsonCFO Sell Plan 3,000158,096 held (−2%) $171.47 $514K -2.5% —
Nov 17SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 900110,684 held (−1%) $171.69 $155K -2.7% —
Nov 16SEC Kelly A. KramerDirector Sell Plan 4,7001,539 held (−75%) $170.49 $801K -2.0% —
Nov 16SEC Kelly A. KramerDirector Sell Plan 3,8006,239 held (−38%) $169.44 $644K -1.4% —
Nov 16SEC Kelly A. KramerDirector Sell Plan 1,67610,039 held (−14%) $168.23 $282K -0.6% —
Nov 16SEC Kelly A. KramerDirector Sell Plan 2001,339 held (−13%) $171.44 $34K -2.5% —
Nov 9SEC Wettan Keeley M. CainEvp Gen Counsel, Legal & Comp Sell Plan 3,3995,360 held (−39%) $164.11 $558K +1.8% —
Nov 6SEC Daniel Patrick O'DayCEO, Chair Sell Plan 102,619551,683 held (−16%) $175.16 $18.0M -4.6% —
Nov 6SEC Daniel Patrick O'DayCEO, Chair Sell Plan 9,810551,683 held (−2%) $175.17 $1.7M -4.6% —
Nov 2SEC Daniel Patrick O'DayCEO, Chair Sell Plan 15,881566,683 held (−3%) $175.25 $2.8M -4.6% —
Nov 2SEC Daniel Patrick O'DayCEO, Chair Sell Plan 7,796553,683 held (−1%) $170.35 $1.3M -1.9% —
Nov 2SEC Daniel Patrick O'DayCEO, Chair Sell Plan 2,000551,683 held (−0%) $171.06 $342K -2.3% —
Nov 2SEC Daniel Patrick O'DayCEO, Chair Sell Plan 1,904561,479 held (−0%) $169.27 $322K -1.3% —
Nov 2SEC Daniel Patrick O'DayCEO, Chair Sell Plan 1,700563,383 held (−0%) $168.10 $286K -0.6% —
Nov 2SEC Daniel Patrick O'DayCEO, Chair Sell Plan 1,600565,083 held (−0%) $167.40 $268K -0.2% —
Oct 16SEC Andrew D. DickinsonCFO Sell Plan 3,000161,096 held (−2%) $156.22 $469K +7.0% —
Oct 16SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 3,000113,684 held (−3%) $156.22 $469K +7.0% —
Oct 2SEC Daniel Patrick O'DayCEO, Chair Sell Plan 12,000569,683 held (−2%) $147.72 $1.8M +13.1% —
Oct 2SEC Daniel Patrick O'DayCEO, Chair Sell Plan 3,000566,683 held (−1%) $148.63 $446K +12.5% —
Sep 16SEC Andrew D. DickinsonCFO Sell Plan 3,000164,096 held (−2%) $145.29 $436K +15.0% —
Sep 16SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 1,600118,084 held (−1%) $143.69 $230K +16.3% —
Sep 16SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 800117,284 held (−1%) $144.46 $116K +15.7% —
Sep 16SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 600116,684 held (−1%) $145.29 $87K +15.0% —
Sep 2SEC Daniel Patrick O'DayCEO, Chair Sell Plan 7,992582,541 held (−1%) $148.36 $1.2M +12.7% —
Sep 2SEC Daniel Patrick O'DayCEO, Chair Sell Plan 5,408577,133 held (−1%) $149.38 $808K +11.9% —
Sep 2SEC Daniel Patrick O'DayCEO, Chair Sell Plan 1,600590,533 held (−0%) $147.51 $236K +13.3% —
Aug 27SEC Anthony WeltersDirector Sell Plan 6,88012,894 held (−35%) $148.82 $1.0M +12.3% —
Aug 27SEC Anthony WeltersDirector Sell Plan 4,60012,894 held (−26%) $148.82 $685K +12.3% —
Aug 27SEC Anthony WeltersDirector Sell Plan 3,40219,774 held (−15%) $148.24 $504K +12.7% —
Aug 27SEC Anthony WeltersDirector Sell Plan 3,11817,494 held (−15%) $148.31 $462K +12.7% —
Aug 21SEC Jeffrey BluestoneDirector Sell Plan 1,81610,066 held (−15%) $144.92 $263K +15.3% —
Aug 21SEC Jeffrey BluestoneDirector Sell Plan 1,65810,066 held (−14%) $145.73 $242K +14.7% —
Aug 21SEC Jeffrey BluestoneDirector Sell Plan 1,16510,066 held (−10%) $143.75 $167K +16.3% —
Aug 21SEC Jeffrey BluestoneDirector Sell Plan 33510,066 held (−3%) $146.26 $49K +14.3% —
Aug 21SEC Jeffrey BluestoneDirector Sell Plan 2610,066 held (−0%) $146.36 $4K +14.2% —
Aug 18SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 16,530129,704 held (−11%) $137.37 $2.3M +21.7% —
Aug 18SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 11,470118,234 held (−9%) $138.04 $1.6M +21.1% —
Aug 18SEC Andrew D. DickinsonCFO Sell Plan 3,000165,646 held (−2%) $138.36 $415K +20.8% —
Aug 4SEC Daniel Patrick O'DayCEO, Chair Sell Plan 7,700592,733 held (−1%) $130.80 $1.0M +27.8% —
Aug 4SEC Daniel Patrick O'DayCEO, Chair Sell Plan 6,700600,433 held (−1%) $129.66 $869K +28.9% —
Aug 4SEC Daniel Patrick O'DayCEO, Chair Sell Plan 600592,133 held (−0%) $131.34 $79K +27.3% —
Jul 16SEC Andrew D. DickinsonCFO Sell Plan 3,000168,646 held (−2%) $129.93 $390K +28.6% —
Jul 16SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 3,000121,234 held (−2%) $129.92 $390K +28.6% —
Jul 2SEC Daniel Patrick O'DayCEO, Chair Sell Plan 11,900610,233 held (−2%) $126.09 $1.5M +32.6% —
Jul 2SEC Daniel Patrick O'DayCEO, Chair Sell Plan 3,100607,133 held (−1%) $127.08 $394K +31.5% —
Jun 16SEC Andrew D. DickinsonCFO Sell Plan 3,000171,646 held (−2%) $125.40 $376K +33.3% —
Jun 16SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 1,480125,754 held (−1%) $123.42 $183K +35.4% —
Jun 16SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 1,070124,684 held (−1%) $124.00 $133K +34.8% —
Jun 16SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 450124,234 held (−0%) $125.40 $56K +33.3% —
Jun 2SEC Daniel Patrick O'DayCEO, Chair Sell Plan 10,900621,667 held (−2%) $131.10 $1.4M +27.5% —
Jun 2SEC Daniel Patrick O'DayCEO, Chair Sell Plan 3,062618,605 held (−0%) $132.22 $405K +26.4% —
Jun 2SEC Daniel Patrick O'DayCEO, Chair Sell Plan 1,038617,567 held (−0%) $132.97 $138K +25.7% —
May 18SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 11,177134,853 held (−8%) $131.19 $1.5M +27.4% —
May 18SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 8,374126,479 held (−6%) $132.23 $1.1M +26.4% —
May 18SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 7,749146,030 held (−5%) $130.29 $1.0M +28.3% —
May 18SEC Andrew D. DickinsonCFO Sell Plan 3,000173,191 held (−2%) $132.27 $397K +26.4% —
May 18SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 700125,779 held (−1%) $132.75 $93K +25.9% —
Apr 29SEC Daniel Patrick O'DayCEO, Chair Sell Plan 6,950635,617 held (−1%) $128.79 $895K +29.8% —
Apr 29SEC Daniel Patrick O'DayCEO, Chair Sell Plan 3,050632,567 held (−0%) $130.01 $397K +28.6% —
Apr 16SEC Andrew D. DickinsonCFO Sell Plan 3,000176,191 held (−2%) $140.96 $423K +18.6% —
Apr 16SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 3,000128,779 held (−2%) $140.96 $423K +18.6% —
Mar 30SEC Daniel Patrick O'DayCEO, Chair Sell Plan 10,000642,567 held (−2%) $136.82 $1.4M +22.2% —
Mar 17SEC Andrew D. DickinsonCFO Sell Plan 3,000179,191 held (−2%) $144.23 $433K +15.9% —
Mar 17SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 3,000131,779 held (−2%) $144.23 $433K +15.9% —
Mar 2SEC Daniel Patrick O'DayCEO, Chair Sell Plan 6,419642,408 held (−1%) $145.18 $932K +15.1% —
Mar 2SEC Daniel Patrick O'DayCEO, Chair Sell Plan 3,481648,827 held (−1%) $144.04 $501K +16.0% —
Mar 2SEC Daniel Patrick O'DayCEO, Chair Sell Plan 100642,308 held (−0%) $145.71 $15K +14.7% —
Feb 18SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 18,405129,883 held (−12%) $154.18 $2.8M +8.4% —
Feb 18SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 9,395120,488 held (−7%) $154.91 $1.5M +7.9% —
Feb 18SEC Andrew D. DickinsonCFO Sell Plan 3,000167,779 held (−2%) $154.43 $463K +8.2% —
Feb 18SEC Johanna MercierChief Comm & Corp Aff Officer Sell Plan 200120,288 held (−0%) $155.62 $31K +7.4% —
Feb 6SEC Daniel Patrick O'DayCEO, Chair Sell Plan 115,640613,912 held (−16%) $150.00 $17.3M +11.4% —
Jan 29SEC Daniel Patrick O'DayCEO, Chair Sell Plan 5,032561,666 held (−1%) $139.54 $702K +19.8% —
Jan 29SEC Daniel Patrick O'DayCEO, Chair Sell Plan 4,968556,698 held (−1%) $140.24 $697K +19.2% —
Jan 26SEC Daniel Patrick O'DayCEO, Chair Sell Plan 115,640566,698 held (−17%) $135.00 $15.6M +23.8% —
Jan 21SEC Jeffrey BluestoneDirector Sell Plan 5,0008,920 held (−36%) $123.50 $618K +35.3% —
Jan 16SEC Andrew D. DickinsonCFO Sell Plan 3,000150,503 held (−2%) $124.31 $373K +34.5% —
Jan 16SEC Johanna MercierChief Commercial Officer Sell Plan 3,000103,221 held (−3%) $124.31 $373K +34.5% —
Dec 30SEC Daniel Patrick O'DayCEO, Chair Sell Plan 10,000566,698 held (−2%) $124.83 $1.2M +33.9% —
Dec 16SEC Andrew D. DickinsonCFO Sell Plan 3,000153,503 held (−2%) $122.00 $366K +37.0% —
Dec 16SEC Johanna MercierChief Commercial Officer Sell Plan 3,000106,221 held (−3%) $122.00 $366K +37.0% —
Dec 1SEC Daniel Patrick O'DayCEO, Chair Sell Plan 6,788571,203 held (−1%) $126.84 $861K +31.8% —
Dec 1SEC Jeffrey BluestoneDirector Sell 5,0008,920 held (−36%) $125.08 $625K +33.6% —
Dec 1SEC Daniel Patrick O'DayCEO, Chair Sell Plan 3,212577,991 held (−1%) $125.91 $404K +32.7% —
Dec 1SEC Kelly A. KramerDirector Sell Plan 2,8061,339 held (−68%) $127.11 $357K +31.5% —
Dec 1SEC Kelly A. KramerDirector Sell Plan 2,8051,339 held (−68%) $127.10 $357K +31.5% —
Nov 18SEC Johanna MercierChief Commercial Officer Sell Plan 25,524109,669 held (−19%) $125.83 $3.2M +32.8% —
Nov 18SEC Andrew D. DickinsonCFO Sell Plan 2,500154,555 held (−2%) $125.23 $313K +33.5% —
Nov 18SEC Johanna MercierChief Commercial Officer Sell Plan 2,476107,193 held (−2%) $126.26 $313K +32.4% —
Nov 13SEC Deborah H. TelmanEvp, Corporate Affairs & Gc Sell Plan 35,96543,676 held (−45%) $122.30 $4.4M +36.7% —
Nov 13SEC Deborah H. TelmanEvp, Corporate Affairs & Gc Sell Plan 17,18143,676 held (−28%) $124.00 $2.1M +34.8% —
Nov 13SEC Deborah H. TelmanEvp, Corporate Affairs & Gc Sell Plan 50043,676 held (−1%) $122.90 $61K +36.0% —
Oct 29SEC Daniel Patrick O'DayCEO, Chair Sell Plan 7,978583,225 held (−1%) $119.54 $954K +39.8% —
Oct 29SEC Daniel Patrick O'DayCEO, Chair Sell Plan 2,022581,203 held (−0%) $118.82 $240K +40.7% —
Oct 16SEC Johanna MercierChief Commercial Officer Sell Plan 3,000110,193 held (−3%) $118.08 $354K +41.5% —
Oct 16SEC Andrew D. DickinsonCFO Sell Plan 2,500157,055 held (−2%) $118.08 $295K +41.5% —
Historical context

Similar past setups: not applicable. GILD has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with GILD in the Research Lab

GILD has no open-market insider buys in the last 12 months. Try the tools with any setup.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

GILD closeInsider buyInsider sale
100120140160180DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-10EEarnings release filed 2026-05-07EEarnings release filed 2026-08-04EEarnings release filed 2026-10-29Sold $356,671 on 2025-11-26 · Kelly A. KramerSold $557,810 on 2026-11-06 · Wettan Keeley M. CainSold $617,500 on 2026-01-20 · Jeffrey BluestoneSold $725,078 on 2026-08-20 · Jeffrey BluestoneSold $732,000 on 2025-12-15 · Andrew D. Dickinson, Johanna MercierSold $745,860 on 2026-01-15 · Andrew D. Dickinson, Johanna MercierSold $747,962 on 2026-06-15 · Andrew D. Dickinson, Johanna MercierSold $779,534 on 2026-07-15 · Andrew D. Dickinson, Johanna MercierSold $845,760 on 2026-04-15 · Andrew D. Dickinson, Johanna MercierSold $865,380 on 2026-03-16 · Andrew D. Dickinson, Johanna MercierSold $868,516 on 2026-09-15 · Andrew D. Dickinson, Johanna MercierSold $937,320 on 2026-10-15 · Andrew D. Dickinson, Johanna MercierSold $1,248,272 on 2025-12-29 · Daniel Patrick O'DaySold $1,291,608 on 2026-04-28 · Daniel Patrick O'DaySold $1,368,162 on 2026-03-27 · Daniel Patrick O'DaySold $1,398,911 on 2026-01-28 · Daniel Patrick O'DaySold $1,447,859 on 2026-02-27 · Daniel Patrick O'DaySold $1,718,418 on 2026-11-05 · Daniel Patrick O'DaySold $1,761,437 on 2026-11-12 · Kelly A. KramerSold $1,894,400 on 2026-07-01 · Daniel Patrick O'DaySold $1,954,694 on 2026-08-03 · Daniel Patrick O'DaySold $1,971,847 on 2026-06-01 · Daniel Patrick O'DaySold $2,218,508 on 2026-10-01 · Daniel Patrick O'DaySold $2,229,592 on 2026-09-01 · Daniel Patrick O'DaySold $2,247,359 on 2025-11-28 · Daniel Patrick O'Day, Jeffrey Bluestone, Kelly A. KramerSold $2,546,102 on 2026-11-02 · Daniel Patrick O'DaySold $2,675,220 on 2026-08-26 · Anthony WeltersSold $2,783,075 on 2026-10-30 · Daniel Patrick O'DaySold $4,073,009 on 2026-05-15 · Andrew D. Dickinson, Johanna MercierSold $4,268,988 on 2026-08-17 · Andrew D. Dickinson, Johanna MercierSold $4,787,518 on 2026-02-17 · Andrew D. Dickinson, Johanna MercierSold $5,289,937 on 2026-11-16 · Andrew D. Dickinson, Johanna MercierSold $15,611,400 on 2026-01-23 · Daniel Patrick O'DaySold $17,346,000 on 2026-02-05 · Daniel Patrick O'DaySold $17,975,021 on 2026-11-04 · Daniel Patrick O'Day
Bought, 12 months$0
Sold, 12 months$109M
Insiders buying0
Insiders selling7

Gilead Sciences insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 7 sold $109M of GILD stock on the open market; P/E 26.6 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

GILD insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $16.9M sold (18 trades)Q4 2025Q1 2026: $44.2M sold (17 trades)Q1 2026Q2 2026: $8.9M sold (16 trades)Q2 2026Q3 2026: $15.4M sold (26 trades)Q3 2026Q4 2026: $35.8M sold (21 trades)Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0$35.8M21
Q3 2026—0$15.4M26
Q2 2026—0$8.9M16
Q1 2026—0$44.2M17
Q4 2025—0$16.9M18

Valuation, profit and volume

P/E (trailing)26.6Sector median 25.0
Volume vs. 50-day0.7×Last 5 sessions

Source: SEC filings, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 0 Gilead Sciences insiders reported open-market purchases totaling $0, while 7 insiders reported sales totaling $109M. 97 of 98 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

GILD earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Oct 29, 2026 +7.6% Sold $3.2M +7.2%S&P -2.1% pending
Aug 4, 2026 -2.3% Sold $2.7M +0.5%S&P +1.6% +14.6%
May 7, 2026 +2.3% Sold $2.1M -3.6%S&P +0.5% -1.7%
Feb 10, 2026 +11.6% Sold $35.7M +2.7%S&P -0.3% -6.4%
Oct 30, 2025 +0.0% Sold $1.8M +1.1%S&P -0.8% +5.1%
Aug 7, 2025 +0.1% None +8.3%S&P +0.7% -3.7%
Apr 24, 2025 +3.1% None -3.0%S&P +2.8% +4.1%
Feb 11, 2025 +2.6% None +8.2%S&P -0.2% +8.6%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

GILD short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 42% of volume sold short2026-08-27: 47% of volume sold short2026-08-28: 31% of volume sold short2026-08-31: 30% of volume sold short2026-09-01: 34% of volume sold short2026-09-02: 35% of volume sold short2026-09-03: 40% of volume sold short2026-09-04: 57% of volume sold short2026-09-08: 37% of volume sold short2026-09-09: 32% of volume sold short2026-09-10: 40% of volume sold short2026-09-11: 41% of volume sold short2026-09-14: 54% of volume sold short2026-09-15: 44% of volume sold short2026-09-16: 56% of volume sold short2026-09-17: 57% of volume sold short2026-09-18: 50% of volume sold short2026-09-21: 55% of volume sold short2026-09-22: 42% of volume sold short2026-09-23: 37% of volume sold short2026-09-24: 23% of volume sold short2026-09-25: 26% of volume sold short2026-09-28: 29% of volume sold short2026-09-29: 33% of volume sold short2026-09-30: 39% of volume sold short2026-10-01: 41% of volume sold short2026-10-02: 52% of volume sold short2026-10-05: 51% of volume sold short2026-10-06: 43% of volume sold short2026-10-07: 57% of volume sold short2026-10-08: 48% of volume sold short2026-10-09: 50% of volume sold short2026-10-12: 45% of volume sold short2026-10-13: 37% of volume sold short2026-10-14: 45% of volume sold short2026-10-15: 49% of volume sold short2026-10-16: 39% of volume sold short2026-10-19: 46% of volume sold short2026-10-20: 43% of volume sold short2026-10-21: 47% of volume sold short2026-10-22: 39% of volume sold short2026-10-23: 52% of volume sold short2026-10-26: 61% of volume sold short2026-10-27: 50% of volume sold short2026-10-28: 53% of volume sold short2026-10-29: 54% of volume sold short2026-10-30: 47% of volume sold short2026-11-02: 41% of volume sold short2026-11-03: 39% of volume sold short2026-11-04: 40% of volume sold short2026-11-05: 35% of volume sold short2026-11-06: 42% of volume sold short2026-11-09: 52% of volume sold short2026-11-10: 53% of volume sold short2026-11-11: 38% of volume sold short2026-11-12: 46% of volume sold short2026-11-13: 40% of volume sold short2026-11-16: 38% of volume sold short2026-11-17: 45% of volume sold short2026-11-18: 51% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 51%20-day average: 45%Prior 2 months: 43%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded GILD

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Thomas H TubervilleSenate Bought $1,001 - $15,000 May 10, 2024Aug 5, 2026 +173.2%
Thomas H TubervilleSenate Bought $1,001 - $15,000 May 10, 2024Aug 5, 2026 +173.2%
Thomas H TubervilleSenate Bought $1,001 - $15,000 May 10, 2024Aug 5, 2026 +173.2%
Thomas H TubervilleSenate Sold $1,001 - $15,000 May 8, 2024Aug 5, 2026 +177.6%
Alan ArmstrongSenate Bought $1,001 - $15,000 Mar 27, 2026Jul 21, 2026 +26.0%

Insiders at Gilead Sciences

InsiderBoughtSoldLast filingPast buys beat S&PScore
Daniel Patrick O'DayCEO, Chair — $77.5M Nov 6, 2026 — —
Johanna MercierChief Comm & Corp Aff Officer — $23.8M Nov 17, 2026 — —
Deborah H. TelmanEvp, Corporate Affairs & Gc — $6.6M Nov 13, 2025 — —
Andrew D. DickinsonCFO — $5.7M Nov 17, 2026 — —
Anthony WeltersDirector — $2.7M Aug 27, 2026 — —
Kelly A. KramerDirector — $2.5M Nov 16, 2026 — —
Jeffrey BluestoneDirector — $2.0M Aug 21, 2026 — —
Wettan Keeley M. CainEvp Gen Counsel, Legal & Comp — $558K Nov 9, 2026 — —
Erin BurkhartSvp, Controllership — — Sep 23, 2026 — —
Dietmar BergerChief Medical Officer — — Sep 11, 2026 — —
Harish ManwaniDirector — — May 4, 2026 — —
Jacqueline K. BartonDirector — — May 4, 2026 — —
Ted W. LoveDirector — — May 4, 2026 — —
Javier RodriguezDirector — — May 4, 2026 — —
Sandra HorningDirector — — May 4, 2026 — —

Board links: companies that share insiders with GILD

Directors and executives who filed Form 4s for GILD and another company in the last 12 months.

See the map →
  • COINCoinbase Kelly A. Kramer Director here · Director at COIN · latest filing Nov 16, 2026
  • DVADaVita Javier Rodriguez Director here · CEO at DVA · latest filing Nov 17, 2026
  • MRNAModerna Sandra Horning Director here · Director at MRNA · latest filing May 4, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

GILD stock: common questions

Are Gilead Sciences insiders buying GILD stock?

No. No Gilead Sciences insider reported an open-market purchase of GILD in the past 12 months.

Are Gilead Sciences insiders selling GILD stock?

7 insiders reported sales worth $109M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is GILD's P/E ratio?

GILD trades at about 26.6 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is GILD's 52-week range?

Over the past year GILD has traded between $116.21 and $174.48. It last closed at $167.13 on Nov 19, 2026.